16
Participants
Start Date
April 13, 2018
Primary Completion Date
July 31, 2020
Study Completion Date
December 31, 2020
Nu-V3
The Nu-V3 device provides a continuous flow of intermittent, low frequency electrical pulses to the ear's specific cranial nerve endings. This treatment is delivered 24 hours a day for the first 12 weeks, then is delivered two weeks on, one week off for the following 12 weeks.
Arizona Endocrinology, Phoenix
Lead Sponsor
Nu-Life Solutions
INDUSTRY